Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ELAPOR2 (Endosome-lysosome associated apoptosis and autophagy regulator family member 2) is a protein-coding gene that encodes a regulatory protein implicated in the modulation of the BMP signaling pathway. It is predicted to localize to the plasma membrane and endosomal/lysosomal compartments. ELAPOR2 plays a role in regulating apoptosis and autophagy, contributing positively to epidermis development and negatively to nervous system development. Diseases associated with dysfunction or aberrant expression of ELAPOR2 include pancreatic acinar cell adenocarcinoma. There is currently limited evidence for direct drug interactions or its use as a biomarker or therapeutic target in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endosome-lysosome associated apoptosis and autophagy regulator family member 2 (ELAPOR2).